| Name | Thrifty White Drug #745 |
|---|---|
| Organization Name | Thrifty Drug Stores Inc |
| Location | 200 Central Ave, Osakis, Minnesota 56360 |
| Type | Supplier |
| Phone | (320) 859-2161 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
E-health is vital to winning the battle against heart disease, European cardiology leaders said today in a European Society of Cardiology position paper published in European Heart Journal. The novel paper outlines how the ESC will exploit e-health in education and research, while tackling issues of quality control and data security.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
Hemoglobin A1c is the standard measurement for assessing glycemic control over time in people with diabetes. Blood levels of A1c are typically measured every few months in a laboratory, but now researchers have developed a data-based model that accurately estimates A1c using self-monitored blood glucose (SMBG) readings, as described in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
The study conducted by Prof. Frank Bradke's team provides indications on brain development and about the causes of diseases of the nervous system. The results have now been published in "Neuron".
› Verified 5 days ago
News Archive
E-health is vital to winning the battle against heart disease, European cardiology leaders said today in a European Society of Cardiology position paper published in European Heart Journal. The novel paper outlines how the ESC will exploit e-health in education and research, while tackling issues of quality control and data security.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
Hemoglobin A1c is the standard measurement for assessing glycemic control over time in people with diabetes. Blood levels of A1c are typically measured every few months in a laboratory, but now researchers have developed a data-based model that accurately estimates A1c using self-monitored blood glucose (SMBG) readings, as described in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
The study conducted by Prof. Frank Bradke's team provides indications on brain development and about the causes of diseases of the nervous system. The results have now been published in "Neuron".
› Verified 5 days ago
Thrifty White Drug #745 Type: Medicare Supplier Location: 200 Central Ave, Osakis, Minnesota 56360 Phone: (320) 859-2161 |